FMO5 and metabolic syndrome: In MetS, hyperglycemia and dyslipidemia activate NADPH oxidase (NOX) enzymes, particularly NOX2 and NOX4, in endothelial cells, adi-pocytes, and vascular smooth muscle cells [31].